Labshake search
Citations for Tocris :
301 - 350 of 545 citations for 7 bromoquinoline 3 carboxylic acid since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2020Quote: ... In all cases 3 mg/ml biocytin (Tocris) was added in the recording solution and no extra pharmacology was added ...
-
bioRxiv - Cell Biology 2021Quote: ... p38 MAPK inhibitor SB203580 (3 uM, Tocris, #1202), JNK inhibitor SP600125 (20uM ...
-
bioRxiv - Neuroscience 2022Quote: ... GABA (500 µL, 3 mM, Tocris Bioscience, 0344), CaCl2 (370 µL ...
-
bioRxiv - Bioengineering 2022Quote: ... 3 μM CHIR99021 (Tocris Bioscience, catalogue no. 4423), 50 nM PI-103 (Tocris Bioscience ...
-
bioRxiv - Developmental Biology 2021Quote: ... 3 mM GSK3 inhibitor CHIR99021 (4953/50 Tocris), and 1,000 U/ml LIF (ESGRO ESG1107 ...
-
bioRxiv - Neuroscience 2021Quote: ... In some cases 3 mg/ml biocytin (Tocris) was added in the recording solution ...
-
bioRxiv - Neuroscience 2022Quote: ... 3) a selective PIEZO1 agonist Yoda1 (5586, Tocris). For pressure pulse stimulation ...
-
bioRxiv - Developmental Biology 2023Quote: ... N2B27 was supplemented with 3 µM CHIR99021 (Tocris), 1 µM PD0325901 (Tocris ...
-
bioRxiv - Neuroscience 2023Quote: ... 3 mM L-glutamate (Glu, #0218, Tocris, UK) and 0.1 mM cyclothiazide (CTZ ...
-
bioRxiv - Bioengineering 2023Quote: ... which included 3 µM CHIR 99021 (Tocris, 4423) +/- 10 µM Y27632 (StemCell Technologies ...
-
bioRxiv - Neuroscience 2019Quote: ... and 50 μM D,L-2-amino-5-phosphonovaleric acid / AP5 (Tocris Bioscience). Coverslips were mounted in an RC-21BRFS chamber (Warner Instruments ...
-
bioRxiv - Neuroscience 2019Quote: ... and 50 µM D-2-amino-5-phosphonovaleric acid (D-AP-5; Tocris) to isolate synaptic inhibitory transmission ...
-
bioRxiv - Immunology 2022Quote: ... PBMCs were first treated with the sialic acid inhibitor P-3FAX-Neu5Ac (Tocris) for 24 hours ...
-
bioRxiv - Neuroscience 2019Quote: ... at concentrations of 34 μM and 340 μM and dihydrokainic acid (DHK) (Tocris), an excitatory amino acid 2 (EAAT2 ...
-
bioRxiv - Microbiology 2021Quote: ... 1 mM orange-red TAMRA-based fluorescent D-amino acid (RADA, Tocris, 6649) was added to the µ-dish ...
-
bioRxiv - Neuroscience 2023Quote: ... and 100 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-APV, Tocris, 0106) to block glutamatergic inputs ...
-
bioRxiv - Neuroscience 2023Quote: ... CNQX and D(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) were from Tocris Biosciences ...
-
bioRxiv - Neuroscience 2023Quote: ... (S)-2-Amino-2-methyl-4-phosphonobutanoic acid (MAP4; 250 µM; Tocris, Item# 0711), Tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2023Quote: ... DL-2- amino-5-phosphono-pentanoic acid (AP5; 50 µM; Tocris, Item# 0105), 4-Aminopyridine (4- AP ...
-
bioRxiv - Neuroscience 2023Quote: ... NMDAR antagonist D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV 50µM, Tocris-0106) and tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2024Quote: ... or kainic acid (1mg/ml dissolved in sterile saline, Tocris; Catalog No: 0222), were injected into the lateral habenula ...
-
bioRxiv - Neuroscience 2019Quote: ... and NMDAR EPSCs were then isolated by addition of the AMPAR antagonist 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, 10 µM; Tocris, Cat# 1044). NMDAR EPSCs were confirmed by addition of the NMDAR antagonist D,L-APV (20 µM ...
-
bioRxiv - Cell Biology 2021Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt (NBQX; #1044) and Kainate (KA; #0222) were purchased from Tocris. L-Glutamic acid monosodium salt (Glu ...
-
bioRxiv - Neuroscience 2020Quote: ... to allow outside-out patch recording and 30 μM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris, Cat#1044) was added to media post-transfection to avoid AMPAR-mediated toxicity.
-
bioRxiv - Physiology 2021Quote: ... L-364,373 (R-L3 or 5-(2-Fluorophenyl)-1,3-dihydro-3-(1H-indol-3-ylmethyl)-1-methyl-2H-1,4-benzodiazepin-2-one) (Tocris Cookson; Bristol, UK) and mefenamic (dimethylphenylaminobenzoic ...
-
bioRxiv - Neuroscience 2020Quote: ... (S)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxy-5-phenylthiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione (ACET; 1μM; Tocris Bioscience, catalog #2728).
-
bioRxiv - Microbiology 2024Quote: To investigate the impact of gallein (3’,4’,5’,6’-Tetrahydroxyspiro[isobenzofuran-1(3H),9’- (9H)xanthen]-3-one) (Cat#3090, Tocris, Minneapolis, MN) and/or INH on Mtb growth ...
-
bioRxiv - Cell Biology 2021Quote: ... or the AMPA-iGluR specific inhibitor 2,3-dioxo-6-nitro-7-sulfamoyl-benzo[f]quinoxaline (NBQX, cat. num. 373, Tocris). Drugs were dissolved in ESC complete media (no 2i ...
-
bioRxiv - Neuroscience 2022Quote: ... were recorded during the application of the competitive AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 20 μM, Tocris) and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Cell Biology 2022Quote: To observe chromosome alignment in fixed-cell experiments – with the advantage of taking high resolution images and easily selecting many cells for further analysis - cells were released from thymidine block for 7 hours before being treated for 2 hours with RO-3306 (10μM, Tocris) – to synchronise cells at the G2/M boundary - or with a 3-hour treatment with STLC (10μM ...
-
bioRxiv - Neuroscience 2019Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (“NBQX”, 100 mM in DMSO, Tocris Cat No 0373); D-2-amino-5-phosphonovalerate (“D-AP5” ...
-
bioRxiv - Cell Biology 2019Quote: ... HeLa FRT cells were released from thymidine block (40 h after siRNA treatment) for 7 hours before arresting at the G2/M boundary with RO-3306 treatment (10μM, Tocris) for 2 hours ...
-
bioRxiv - Neuroscience 2023Quote: ... slices were incubated in recording ACSF supplemented with 5 μM 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, Tocris, 1045) and 100 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-APV ...
-
bioRxiv - Neuroscience 2022Quote: ... drugs were bath applied at the following concentrations (in μM): 10 6-Cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX, Tocris), 50 D-2-amino-5-phosphonopentanoic acid (D-APV ...
-
bioRxiv - Neuroscience 2023Quote: ... L-glutamate was locally photo-released from 1 mM 4-Methoxy-7-nitroindolinyl-caged-L-glutamate (MNI-glutamate, TOCRIS) using an OPTOLED pulse of 1 ms at 365 nM wavelength ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... were recorded at −70mV in presence of 20□μM CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione disodium, an AMPA receptor antagonist, Tocris) and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid ...
-
bioRxiv - Developmental Biology 2021Quote: ... N2B27 medium was supplemented with CHIR99021 (3 μM, Tocris), FGF2 (20 ng/ml ...
-
bioRxiv - Neuroscience 2020Quote: ... and 3 μM CHIR99021 (Tocris Bioscience, Cat N° 4423) for 2 days with medium changes every day (=day 0-1) ...
-
bioRxiv - Cell Biology 2021Quote: ... 3 μM of p38 MAPK inhibitor SB203580 (Tocris, #1202) or NLRP3 inflammasome inhibitor MCC950 (1uM ...
-
bioRxiv - Neuroscience 2020Quote: Clozipine-N-Oxide dihydrochloride (CAS2250025-93-3, Tocris Biosciences) was injected intraperitoneally (i.p. ...
-
bioRxiv - Developmental Biology 2020Quote: ... directly into N2B27 medium containing CHIR99021 (3 µM, Tocris), FGF2 (20 ng/ml ...
-
bioRxiv - Neuroscience 2019Quote: ... and (R)-Baclofen (catalog # 0796, Batch No. 3; Tocris). (±)-Bay K 8644 and Nefiracetam were dissolved in DMSO to a 100 mM stock solution and (R)-Baclofen was dissolved in water (with gentle warming ...
-
bioRxiv - Neuroscience 2022Quote: ... The mGlu2/3 agonist LY379268 was obtained from Tocris (Cat# ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... Zatebradine hydrochloride (Tocris, Cas Registry No. 91940-87-3) and ZD7288 (Tocris ...
-
Presynaptic mitochondria volume and abundance increase during development of a high-fidelity synapsebioRxiv - Neuroscience 2019Quote: ... the standard extracellular solution was supplemented with 1 mM kynurenic acid (Tocris, Cat# 0223) to avoid desensitization and saturation of postsynaptic AMPA receptors ...
-
bioRxiv - Neuroscience 2019Quote: ... an excitatory amino acid transporter (EAATs) blocker DL-TBOA (100 µM, Tocris Bioscience, UK) was added to the bath ...
-
bioRxiv - Neuroscience 2021Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 μM, Tocris Bioscience, Bristol, UK) were diluted to the appropriate concentration from stock solutions and added to the bath through the perfusion system for 10 minutes before recordings ...
-
bioRxiv - Neuroscience 2021Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 μM, Tocris Bioscience, Bristol, UK) were diluted to the appropriate concentration from stock solutions and added to the Ames medium before recordings.
-
bioRxiv - Neuroscience 2022Quote: ... and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5; 50 μM, Tocris).
-
bioRxiv - Neuroscience 2020Quote: ... DL-2-Amino-5-phosphonopentanoic acid sodium salt (AP5, Cat. No. 3693, Tocris, UK), (-)-Bicuculline methochloride (Cat ...